Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 2/20 | 0.35 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | CASP7 | P55210 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1365239 | 0.77 | NR4A2 (0.39) | PIN1HTR2AHTR2CIDH1NR4A2 | |
| SCHEMBL646093 | 0.74 | ALDH1A1 (0.42) | HSD17B10KDM4EMAPTHIF1APIN1 | |
| SCHEMBL13857953 | 0.74 | PSMD14 (0.42) | PIN1HTR2AHTR2CIDH1NR4A2 | |
| SCHEMBL5687278 | 0.74 | BACE1 (0.35) | PIN1IDH1NR4A2DHODHEPHB4 | |
| SCHEMBL288687 | 0.74 | PIN1 (0.35) | PIN1IDH1NR4A2DHODHEPHB4 | |
| SCHEMBL2005830 | 0.74 | PIN1 (0.40) | PIN1DYRK1AALDH1A1ELANESMN1; SMN2 | |
| SCHEMBL17177020 | 0.74 | PIN1 (0.35) | PIN1IDH1NR4A2DHODHEPHB4 | |
| SCHEMBL3356073 | 0.74 | NR4A2 (0.38) | KDM4EMAPTPARP1PIN1ALDH1A1 | |
| SCHEMBL288688 | 0.74 | ELANE (0.43) | KDM4EPARP1PIN1TSHRALDH1A1 | |
| SCHEMBL1881059 | 0.74 | PIN1 (0.40) | MAPTPARP1PIN1TDP1DYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118359961-A | Water-based ink capable of rapidly detecting trace migration and detection method thereof | 上海高邦印刷材料有限公司 | 2024-07-19 | — | — | CN | claimed |
| CN-110156712-A | It is a kind of to utilize aromatic nitration by-product synthesis benzoxazoles class compound and application | 邵玉田 | 2019-08-23 | — | — | CN | claimed |
| CN-110105568-A | A method of utilizing aromatic nitration by-product production PBI functional material | 邵玉田 | 2019-08-09 | — | — | CN | claimed |
| EP-4709384-A2 | COMBINATION THERAPY FOR TREATMENT OF CANCER | PMV Pharmaceuticals, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| US-20250326760-A1 | TYK2 INHIBITORS AND USES THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-10-23 | — | — | US | disclosed |
| EP-4605392-A1 | METHODS FOR TREATING CANCER | Antares Therapeutics, Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| CN-116217566-B | Anti-apoptosis protein BCL-2 inhibitor, pharmaceutical composition and application thereof | 杭州和正医药有限公司 | 2025-05-23 | — | — | CN | disclosed |
| US-20250034135-A1 | ANTI-APOPTOTIC PROTEIN BCL-2 INHIBITOR, PHARMACEUTICAL COMPOSITION AND USES THEREOF | Hangzhou Healzen Therapeutics Co., Ltd. (CN) | 2025-01-30 | — | — | US | disclosed |
| CN-119156230-A | Ligand-drug conjugates and uses thereof | 江苏先声药业有限公司 | 2024-12-17 | — | — | CN | disclosed |
| US-20240400556-A1 | AMIDOPYRIMIDONE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2024-12-05 | — | — | US | disclosed |
| US-20240400531-A1 | HERBICIDAL MALONAMIDES CONTAINING A CONDENSED RING SYSTEM | BASF SE (DE) | 2024-12-05 | — | — | US | disclosed |
| US-20080305051-A1 | Menthane Carboxamide Derivatives Having Cooling Properties | GIVAUDAN S.A. (CH) | 2008-12-11 | — | — | US | disclosed |
| CN-101137660-A | Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds | HOFFMANN LA ROCHE (CH) | 2008-03-05 | — | — | CN | disclosed |
| EP-1853565-A1 | MENTHANE CARBOXAMIDE DERIVATIVES HAVING COOLING PROPERTIES | Givaudan SA (CH) | 2007-11-14 | — | — | EP | disclosed |
| WO-2006092074-A1 | MENTHANE CARBOXAMIDE DERIVATIVES HAVING COOLING PROPERTIES | GIVAUDAN SA (CH) | 2006-09-08 | — | — | WO | disclosed |
| EP-1509515-A4 | SUBSTITUTED 4-ARYL-4H-PYRROLO 2,3-H CHROMENES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF | CYTOVIA INC (US) | 2006-07-05 | — | — | EP | disclosed |
| US-20060104998-A1 | Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. (US) | 2006-05-18 | — | — | US | disclosed |
| EP-1509515-A2 | SUBSTITUTED 4-ARYL-4H-PYRROLO 2,3-H CHROMENES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF | Cytovia, Inc. (US) | 2005-03-02 | — | — | EP | disclosed |
| WO-2003097806-A2 | SUBSTITUTED 4-ARYL-4H-PYRROLO[2,3-H]CHROMENES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF | CYTOVIA, INC. (US) | 2003-11-27 | — | — | WO | disclosed |
| WO-2003053960-A2 | QUINLINE DERIVATES AND THEIR USE AS MEK INHIBITORS | ASTRAZENECA AB (SE) | 2003-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060104998-A1 | Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof | CASP3, CASP4, CASP2 | HSD17B10 799/4885KDM4E 486/4885MAPT 4700/4885 |
| US-20240400531-A1 | HERBICIDAL MALONAMIDES CONTAINING A CONDENSED RING SYSTEM | DDT, ME3, ME1 | HSD17B10 449/4885KDM4E 244/4885MAPT 1816/4885 |
| US-20250034135-A1 | ANTI-APOPTOTIC PROTEIN BCL-2 INHIBITOR, PHARMACEUTICAL COMPOSITION AND USES THEREOF | BCL2, BAX, BCL2L1 | HSD17B10 3375/4885KDM4E 3877/4885MAPT 2800/4885 |
| US-20250326760-A1 | TYK2 INHIBITORS AND USES THEREOF | TYK2, JAK2, JAK1 | HSD17B10 2692/4885KDM4E 391/4885MAPT 1236/4885 |
| US-20080305051-A1 | Menthane Carboxamide Derivatives Having Cooling Properties | MDH2, ME2, H1-0 | HSD17B10 687/4885KDM4E 10/4885MAPT 1003/4885 |
| US-20240400556-A1 | AMIDOPYRIMIDONE DERIVATIVES | F12, XDH, CYP3A43 | HSD17B10 2286/4885KDM4E 2655/4885MAPT 4070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.